Physician profile
Veronica Lerma
NPI 1720442023
$547.66
in general payments reported to CMS, 2019-2025
12 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2024: $279 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $161.30 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $100.55 | 2021-2024 | Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $40.88 | 2024 | Inspire |
| Corcept Therapeutics | $37.44 | 2025 | Korlym |
| Eisai INC. | $37.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.98 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $29.78 | 2021-2024 | Farxiga |
| Amgen INC. | $27.65 | 2021-2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $24.59 | 2024 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $19.19 | 2021 | |
| Exact Sciences Corporation | $16.72 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Lerma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.